GLABF (Gemina Laboratories) Receivables Turnover: 0.00 (As of Oct. 2025)


What is Gemina Laboratories Receivables Turnover?

Gemina Laboratories GLABF -27.59% Receivables Turnover is 0.00 as of Oct. 2025. The stock has 2 warning signs investors should review.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Gemina Laboratories's Revenue for the three months ended in Oct. 2025 was $0.00 Mil. Gemina Laboratories's average Accounts Receivable for the three months ended in Oct. 2025 was $0.00 Mil.

Gemina Laboratories  (OTCPK:GLABF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Gemina Laboratories Receivables Turnover Related Terms

Gemina Laboratories Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Receivables Turnover Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Receivables Turnover
0.00 0.00 0.00 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GLABF vs VRTX, REGN, ALNY: Receivables Turnover Comparison

For the Biotechnology subindustry, Gemina Laboratories's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Receivables Turnover falls into.


Gemina Laboratories Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Gemina Laboratories's Receivables Turnover for the fiscal year that ended in Jan. 2025 is calculated as

Receivables Turnover (A: Jan. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jan. 2025 ) / ((Accounts Receivable (A: Jan. 2024 ) + Accounts Receivable (A: Jan. 2025 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

Gemina Laboratories's Receivables Turnover for the quarter that ended in Oct. 2025 is calculated as

Receivables Turnover (Q: Oct. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Oct. 2025 ) / ((Accounts Receivable (Q: Jul. 2025 ) + Accounts Receivable (Q: Oct. 2025 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Gemina Laboratories (GLABF) has a Receivables Turnover of 0.00 as of Oct. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Receivables Turnover too high?
Gemina Laboratories' current Receivables Turnover is 0.00.
How does Gemina Laboratories' Receivables Turnover compare to VRTX and REGN?
Gemina Laboratories' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.28, based on 843 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Gemina Laboratories and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gemina Laboratories's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Receivables Turnover is 0.00 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.